Article Information
History
- September 12, 2018.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Petter Säwéna,
- Mohamed Eldeeba,
- Eva Erlandssona,
- Trine A Kristiansena,
- Cecilia Laterzad,e,
- Zaal Kokaiad,e,
- Göran Karlssona,d,e,
- Joan Yuana,d,e,
- Shamit Sonejia,d,e,
- Pankaj K. Mandalb,c,
- Derrick J Rossib,c and
- David Brydera,d,e,f
- aLund University, Medical Faculty, Department of Laboratory Medicine, Division of Molecular Hematology, Klinikgatan 26, BMC B12, 221 84, Lund, Sweden
- bDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA
- cProgram in Cellular and Molecular Medicine, Division of Hematology/Oncology, Boston Children’s Hospital, MA 02116, USA
- dStemTherapy, Lund University
- eLund Stem Cell Center, Lund University
- fSahlgrenska Cancer Center, Gothenburg University
- Corresponding author:
David Bryder, Adress:
Lund University, Medical Faculty, Department of Laboratory Medicine, Division of Molecular Hematology, Klinikgatan 26, BMC B12, 221 84, Lund, Sweden, E-mail:
David.Bryder{at}med.lu.se, Phone number:
+46-46-2223951